355 related articles for article (PubMed ID: 15166496)
1. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor.
Kusumanto YH; Dam WA; Hospers GA; Meijer C; Mulder NH
Angiogenesis; 2003; 6(4):283-7. PubMed ID: 15166496
[TBL] [Abstract][Full Text] [Related]
2. Platelet: transporter of vascular endothelial growth factor.
Verheul HM; Hoekman K; Luykx-de Bakker S; Eekman CA; Folman CC; Broxterman HJ; Pinedo HM
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2187-90. PubMed ID: 9815613
[TBL] [Abstract][Full Text] [Related]
3. Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets.
Werther K; Christensen IJ; Nielsen HJ
Scand J Clin Lab Invest; 2002; 62(5):343-50. PubMed ID: 12387579
[TBL] [Abstract][Full Text] [Related]
4. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor.
Salven P; Orpana A; Joensuu H
Clin Cancer Res; 1999 Mar; 5(3):487-91. PubMed ID: 10100697
[TBL] [Abstract][Full Text] [Related]
5. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.
Banks RE; Forbes MA; Kinsey SE; Stanley A; Ingham E; Walters C; Selby PJ
Br J Cancer; 1998 Mar; 77(6):956-64. PubMed ID: 9528841
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs.
Iba O; Matsubara H; Nozawa Y; Fujiyama S; Amano K; Mori Y; Kojima H; Iwasaka T
Circulation; 2002 Oct; 106(15):2019-25. PubMed ID: 12370229
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker.
Niers TM; Richel DJ; Meijers JC; Schlingemann RO
PLoS One; 2011; 6(5):e19873. PubMed ID: 21637343
[TBL] [Abstract][Full Text] [Related]
9. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis.
Fürstenberger G; von Moos R; Senn HJ; Boneberg EM
Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694
[TBL] [Abstract][Full Text] [Related]
10. Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study.
Salgado R; Benoy I; Bogers J; Weytjens R; Vermeulen P; Dirix L; Van Marck E
Angiogenesis; 2001; 4(1):37-43. PubMed ID: 11824377
[TBL] [Abstract][Full Text] [Related]
11. Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis.
Cressey R; Wattananupong O; Lertprasertsuke N; Vinitketkumnuen U
BMC Cancer; 2005 Oct; 5():128. PubMed ID: 16202150
[TBL] [Abstract][Full Text] [Related]
12. Serum vascular endothelial growth factor in breast cancer.
Byrne GJ; McDowell G; Agarawal R; Sinha G; Kumar S; Bundred NJ
Anticancer Res; 2007; 27(5B):3481-7. PubMed ID: 17972505
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.
Griga T; Werner S; Köller M; Tromm A; May B
Dig Dis Sci; 1999 Jun; 44(6):1196-201. PubMed ID: 10389696
[TBL] [Abstract][Full Text] [Related]
14. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients.
Benoy I; Salgado R; Colpaert C; Weytjens R; Vermeulen PB; Dirix LY
Clin Breast Cancer; 2002 Jan; 2(4):311-5. PubMed ID: 11899364
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
Peng HL; Hu GY; Zhang GS; Gong FJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen?
Lee JK; Hong YJ; Han CJ; Hwang DY; Hong SI
Int J Oncol; 2000 Jul; 17(1):149-52. PubMed ID: 10853032
[TBL] [Abstract][Full Text] [Related]
18. VEGF concentrations in tumour arteries and veins from patients with rectal cancer.
Werther K; Bülow S; Hesselfeldt P; Jespersen NF; Svendsen MN; Nielsen HJ
APMIS; 2002 Sep; 110(9):646-50. PubMed ID: 12529018
[TBL] [Abstract][Full Text] [Related]
19. The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis.
Solanilla A; Villeneuve J; Auguste P; Hugues M; Alioum A; Lepreux S; Ducroix JP; Duhaut P; Conri C; Viallard JF; Nurden AT; Constans J; Ripoche J
Rheumatology (Oxford); 2009 Sep; 48(9):1036-44. PubMed ID: 19549789
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived VEGF, Flt-1, angiopoietin-1 and P-selectin in breast and prostate cancer: further evidence for a role of platelets in tumour angiogenesis.
Caine GJ; Lip GY; Blann AD
Ann Med; 2004; 36(4):273-7. PubMed ID: 15224653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
